Enhanced Medium Chain Triglyceride Compositions for Brain Energy Deficiency Conditions

This inventive concept relates to novel medium chain triglyceride compositions optimized for rapid ketone production, enhanced cognitive function, and improved brain energy metabolism in individuals with brain energy deficiency conditions or neurological diseases.

The original patent disclosed medium chain triglyceride compositions for treating brain energy deficiency conditions, but had limitations in terms of ketone production, cognitive function, and bioavailability. The present inventive concept addresses these limitations by introducing optimized ratios of MCT-C8 to MCT-C10, controlled-release dosage forms, tailored emulsifiers, and customizable ratios based on individual metabolic profiles.

The new claims introduce a system for treating brain energy deficiency conditions comprising a medium-chain triglyceride composition with an optimized ratio of MCT-C8 to MCT-C10 for rapid ketone production. This composition is administered in a controlled-release dosage form to provide a sustained energy boost to the brain. Additionally, a method for enhancing cognitive function in individuals with neurological conditions is disclosed, comprising administering a MCT composition with a tailored ratio of MCT-C8 to MCT-C10 to promote increased C10 fatty acid production and absorption. A novel emulsifier is also introduced to enhance bioavailability and absorption of the MCTs, thereby increasing ketone production and energy delivery to the brain.

The new claims introduce several novel and non-obvious features, including the optimized ratio of MCT-C8 to MCT-C10 for rapid ketone production, the controlled-release dosage form, the tailored emulsifier, and the customizable ratio based on individual metabolic profiles. These features provide a significant improvement over the original patent and demonstrate an inventive step.

Alternative embodiments of the inventive concept include using different ratios of MCT-C8 to MCT-C10, varying the type and amount of emulsifier, and incorporating additional ingredients to enhance cognitive function or neuroprotective effects. Variations of the inventive concept may also include different dosage forms, such as capsules, tablets, or liquids.

The enhanced medium chain triglyceride compositions have significant commercial potential in the nutraceutical and pharmaceutical industries, particularly in the areas of brain health, cognitive function, and neurological diseases. The target market includes individuals with brain energy deficiency conditions, such as Alzheimer's disease, Parkinson's disease, and epilepsy, as well as those seeking to improve cognitive function and overall brain health.